Lower Urinary Tract Cancer

被引：17
作者：
Cannon, Claire M. [1 ]
Allstadt, Sara D. [2 ]
机构：
[1] Univ Tennessee, Coll Vet Med, Dept Small Anim Clin Sci, Knoxville, TN 37996 USA
[2] BluePearl Vet Partners, Louisville, KY 40223 USA
来源：
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE | 2015年 / 45卷 / 04期
关键词：
Transitional cell carcinoma; Prostate tumor; Chemotherapy; Radiation therapy; TRANSITIONAL-CELL-CARCINOMA; CANINE PROSTATE CARCINOMA; INVASIVE BLADDER-CANCER; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CATS PRIONAILURUS-VIVERRINUS; NEEDLE-ASPIRATION BIOPSY; URETHRAL OBSTRUCTION; CLINICAL-TRIAL; MICROBIOLOGIC FINDINGS; PHOTODYNAMIC THERAPY;
D O I：
10.1016/j.cvsm.2015.02.008
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
Lower urinary tract neoplasia is uncommon in dogs and cats, though transitional cell carcinoma (TCC) is the most common tumor of the lower urinary tract in both species. Clinical signs are not specific for neoplasia, but neoplasia should be considered in patients that are older, have specific risk factors, or have persistent, severe, or relapsing signs. Local disease is often the cause of death or euthanasia; local control is challenging owing to tumor size and location. Systemic therapy is the mainstay of treatment. Prognosis is generally guarded, but therapy can result in improvement in clinical signs and quality of life.
引用
收藏
页码：807 / +
页数：19
相关论文
共 105 条
  • [1] Phase I Clinical Trial and Pharmacokinetics of Intravesical Mitomycin C in Dogs with Localized Transitional Cell Carcinoma of the Urinary Bladder
    Abbo, A. H.
    Jones, D. R.
    Masters, A. R.
    Stewart, J. C.
    Fourez, L.
    Knapp, D. W.
    [J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2010, 24 (05): : 1124 - 1130
  • [2] Clinical Trial of Vinblastine in Dogs with Transitional Cell Carcinoma of the Urinary Bladder
    Arnold, E. J.
    Childress, M. O.
    Fourez, L. M.
    Tan, K. M.
    Stewart, J. C.
    Bonney, P. L.
    Knapp, D. W.
    [J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2011, 25 (06): : 1385 - 1390
  • [3] Assin R, 2008, IN VIVO, V22, P755
  • [4] Nanoparticulate paclitaxel demonstrates antitumor activity in PC3 and Ace-1 aggressive prostate cancer cell lines
    Axiak-Bechtel, Sandra M.
    Kumar, Senthil R.
    Dank, Kristin K.
    Clarkson, Nicole A.
    Selting, Kim A.
    Bryan, Jeffrey N.
    Rosol, Thomas J.
    Espinosa, Jahna
    Decedue, Charles J.
    [J]. INVESTIGATIONAL NEW DRUGS, 2013, 31 (06) : 1609 - 1615
  • [5] BARRETT RE, 1976, CORNELL VET, V66, P14
  • [6] BELL FW, 1991, J AM VET MED ASSOC, V199, P1623
  • [7] Lymphoma affecting the urinary bladder in three dogs and a cat
    Benigni, Livia
    Lamb, Christopher R.
    Corzo-Menendez, Nuria
    Holloway, Andrew
    Eastwood, Jane M.
    [J]. VETERINARY RADIOLOGY & ULTRASOUND, 2006, 47 (06) : 592 - 596
  • [8] Evaluation of outcome following urethral stent placement for the treatment of obstructive carcinoma of the urethra in dogs: 42 cases (2004-2008)
    Blackburn, Amanda L.
    Berent, Allyson C.
    Weisse, Chick W.
    Brown, Dorothy C.
    [J]. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2013, 242 (01): : 59 - 68
  • [9] Clinical features, survival times and COX-1 and COX-2 expression in cats with transitional cell carcinoma of the urinary bladder treated with meloxicam
    Bommer, Nicholas X.
    Hayes, Alison M.
    Scase, Timothy J.
    Gunn-Moore, Danielle A.
    [J]. JOURNAL OF FELINE MEDICINE AND SURGERY, 2012, 14 (08) : 527 - 533
  • [10] Boria P A, 2005, Vet Comp Oncol, V3, P73, DOI 10.1111/j.1476-5810.2005.00070.x
12345678910